U.S. health agency advises easing federal marijuana restrictions


Health and Human Services Secretary Xavier Becerra said Wednesday that federal health officials had delivered "a scheduling recommendation for marijuana" to the Drug Enforcement Administration, and Senate Democrats confirmed that HHS's advice was to ease up. President Biden had asked HHS to review marijuana's legal classification last October, at the same time he pardoned thousands of Americans convicted of "simple possession" of the drug.
Currently, marijuana is classified as a Schedule I drug, like heroin and LSD. Senate Majority Leader Chuck Schumer (D-N.Y.) said HHS urged the DEA to make it a Schedule III drug, the same tier as ketamine and some anabolic steroids. "HHS has done the right thing," Schumer said. "DEA should now follow through on this important step to greatly reduce the harm caused by draconian marijuana laws." The DEA's review of the proposed policy change could take months.
Rescheduling marijuana "would reduce or potentially eliminate criminal penalties for possession," The Associated Press explained. It wouldn't legalize the drug but it would make it easier to research the health benefits and drawbacks of cannabis, and it would remove many federal hurdles for selling the drug in the 23 states that have legalized recreational use and the 38 states where marijuana is legal for medicinal use, The Washington Post added.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"We believe that rescheduling to Schedule III will mark the most significant federal cannabis reform in modern history," said Edward Conklin of the U.S. Cannabis Council. "President Biden is effectively declaring an end to Nixon's failed war on cannabis and placing the nation on a trajectory to end prohibition." Sen. Ron Wyden (D-Ore) agreed that making marijuana a Schedule III drug is "is not inconsequential," but he urged Congress to deschedule it altogether.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
October books: an academic analysis of Taylor Swift and the solution to your digital addiction
The Week Recommends This month's new releases include ‘Taylor’s Version’ by Stephanie Burt, ‘Enshittification’ by Cory Doctorow and ‘Minor Black Figures’ by Brandon Taylor
-
Auto loans: Trouble in the subprime economy
Feature The downfall of Tricolor Holdings may reflect the growing financial strain low-income Americans are facing
-
6 eye-catching rounded homes
Feature Featuring a central spiral staircase in Michigan and a Balinese-style estate with ocean views in Hawaii
-
Can TrumpRx really lower drug prices?
Today’s Big Question Pfizer’s deal with Trump sent drugmaker stocks higher
-
FDA OKs generic abortion pill, riling the right
Speed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shot
Speed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
The UK’s opioid crisis: why the stats don’t add up
The Explainer A new report has revealed that the UK’s total of opioid-related deaths could be much greater than official figures show
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Why the FDA wants to restrict kratom-related products
In the Spotlight The compound is currently sold across the United States
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy